+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Spinal Devices & Biologics Market - Global Forecast 2026-2032- Product Image
Spinal Devices & Biologics Market - Global Forecast 2026-2032- Product Image
Sale

Spinal Devices & Biologics Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012075
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Spinal Devices & Biologics Market is projected to reach USD 15.55 Billion in 2026. It is expected to continue growing at a CAGR of 17.21%, reaching USD 40.45 Billion by 2032.

The spinal devices and biologics market is being reshaped by the global burden of degenerative spine disease, trauma, deformity, and cancer-related spinal instability. The World Health Organization reports that low back pain affected 619 million people in 2020 and is projected to affect 843 million people by 2050, making spine care a durable demand category for hospitals, ambulatory surgery centers, payers, and medical technology stakeholders.

Demand is supported by aging demographics, expanding access to advanced imaging, higher adoption of minimally invasive spine surgery, and continued innovation in spinal fusion devices, motion preservation systems, navigation-enabled implants, bone graft substitutes, demineralized bone matrices, cellular allografts, and synthetic biologics. At the same time, evidence standards, value-based procurement, and regulatory scrutiny are increasing, requiring manufacturers to demonstrate safety, fusion performance, cost-effectiveness, and real-world clinical utility.

Transformative Shifts in the Spine Care Landscape

The landscape is shifting from volume-led implant sales toward procedure optimization, outcomes evidence, and biologically informed care pathways. Surgeons and health systems are prioritizing solutions that reduce operating time, improve implant placement accuracy, support fusion consistency, and lower revision risk, while payers increasingly scrutinize indications for fusion, premium biologics, and site-of-care economics.

Minimally invasive techniques, expandable interbody cages, 3D-printed porous titanium, patient-specific planning, robotic guidance, and advanced graft materials are changing competitive differentiation. Regulatory frameworks such as the U.S. FDA 510(k), PMA, and biologics pathways, the European Union Medical Device Regulation, and country-specific reimbursement reviews are creating higher barriers for unsubstantiated claims and favoring manufacturers with strong clinical evidence, post-market surveillance, traceability, and quality systems.

Cumulative Impact of Artificial Intelligence in Spine Care

Artificial intelligence is producing a cumulative impact across the spinal devices and biologics value chain. In preoperative planning, AI-supported imaging can assist with segmentation, sagittal alignment assessment, deformity measurement, and surgical simulation. Intraoperatively, navigation and robotic platforms use data-rich workflows to support screw trajectory planning and implant placement, while postoperative analytics can help identify complications, nonunion risk, readmission patterns, and rehabilitation needs.

The U.S. FDA has documented a rapidly expanding universe of AI- and machine learning-enabled medical devices, with radiology and surgical planning among the most active categories. For spine technology developers, the near-term opportunity is not replacing clinical judgment but embedding AI into validated workflows that improve consistency, documentation, and decision support. Leaders will need transparent algorithms, cybersecurity controls, bias testing, interoperability, and evidence that AI-enabled tools improve measurable outcomes rather than simply adding capital cost.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East, and Africa

Asia-Pacific is a high-potential region driven by large patient populations, fast-rising hospital infrastructure, and aging societies in Japan, China, South Korea, and Australia, while India and Southeast Asia expand access to private specialty care and minimally invasive spine procedures. North America remains an innovation anchor because of advanced surgeon adoption, strong implant utilization, FDA-cleared technologies, established reimbursement pathways, and extensive use of outpatient and ambulatory surgery center models for appropriate spine procedures.

Europe is shaped by mature clinical practice, aging populations, and stricter evidence requirements under the EU MDR, creating demand for proven spinal implants and biologics with robust post-market clinical data. Latin America, led by Brazil and Mexico, is expanding through private hospitals and medical tourism but remains sensitive to currency volatility, import dependence, and reimbursement limitations. The Middle East is investing in tertiary hospitals and specialty orthopedics, particularly across Gulf health systems, while Africa presents long-term access opportunities constrained by limited specialist capacity, infrastructure gaps, affordability barriers, and uneven availability of advanced spine surgery.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN markets are benefiting from hospital modernization, regional medical tourism, and gradual alignment of medical device registration practices, although pricing, reimbursement, and access vary widely across member states. The GCC is increasing demand for premium spine technologies through government-backed healthcare transformation, centralized procurement, and investments in complex orthopedic and neurosurgical capacity.

The European Union is prioritizing safety, traceability, clinical evaluation, and post-market surveillance under MDR, creating advantages for manufacturers with compliant technical documentation and post-market clinical follow-up. BRICS countries represent scale, manufacturing localization, and rising middle-class demand, but require country-specific pricing, tendering, and regulatory strategies. G7 markets continue to lead in R&D intensity, surgeon training, reimbursement sophistication, and clinical adoption, while NATO countries are placing greater emphasis on supply chain resilience, trauma readiness, cybersecurity, and secure medical technology sourcing.

Key Country Insights Across Major Spine Care Markets

The United States is the leading innovation hub for spinal implants, biologics, navigation, robotics, and outpatient spine procedures, supported by FDA pathways, large hospital networks, and strong specialist density. Canada emphasizes publicly funded access, clinical appropriateness, and cost-effectiveness, while Mexico combines domestic demand with cross-border care and private hospital growth. Brazil leads Latin America in orthopedic and neurosurgical capacity, with opportunities tied to private reimbursement, public procurement, and distributor strength.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are mature spine care markets shaped by aging populations, surgeon expertise, national health technology assessment processes, and tightening value expectations, while Russia remains influenced by localization, procurement dynamics, and access variability. China is scaling domestic manufacturing and volume-based procurement, India is expanding private spine centers and affordability-focused implants, Japan prioritizes elderly spine care and precision technologies, Australia supports high-quality specialist care through advanced hospital networks, and South Korea is recognized for advanced hospitals, rapid technology adoption, and regional medical tourism.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical evidence, real-world outcomes, and health economic value for spinal fusion devices, motion preservation systems, and biologics. Companies that can document fusion performance, revision reduction, shorter length of stay, lower complication risk, and workflow efficiency will be better positioned in value-based procurement and payer review.

Manufacturers should build differentiated portfolios around minimally invasive access, expandable and 3D-printed implants, biologics with defensible science, navigation compatibility, and AI-enabled planning. Regional strategies should combine premium innovation in G7 markets with affordability, localization, tender readiness, and distributor excellence in BRICS, ASEAN, Latin America, the Middle East, and Africa. Compliance, post-market surveillance, cybersecurity, supply chain resilience, and surgeon education must be treated as strategic assets rather than operational requirements.

Research Methodology

The research methodology applies triangulated secondary research, primary interviews, and analytical validation to develop verified insights on spinal devices and biologics. Sources include regulatory databases, product clearances and approvals, hospital procurement indicators, reimbursement policies, clinical guidelines, peer-reviewed literature, patent activity, adverse event databases, and public health datasets from institutions such as WHO, OECD, UN agencies, the U.S. FDA, and national health authorities.

Assumptions are validated through expert discussions with manufacturers, distributors, surgeons, procurement leaders, payers, regulatory professionals, and clinical specialists. The analysis evaluates product categories, technology adoption, regional demand drivers, pricing pressures, supply chain risks, competitive positioning, quality requirements, and evidence standards to ensure that insights are commercially relevant and grounded in verifiable data.

Conclusion

The spinal devices and biologics market is entering a more evidence-driven and digitally enabled phase. Demographic aging, the rising burden of low back pain, and expanding access to advanced spine surgery will sustain demand, while regulatory and reimbursement pressure will separate clinically validated solutions from products with limited differentiation.

The strongest competitors will integrate implant engineering, biologic science, AI-enabled planning, navigation, real-world evidence, cybersecurity, and region-specific market access strategies. Success will depend on proving measurable value for surgeons, hospitals, payers, and patients across both mature and emerging spine care systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Spinal Devices & Biologics Market, by Product Category
7.1. Introduction
7.2. Biologics
7.2.1. Allografts
7.2.2. Autografts
7.2.3. Recombinant Growth Factors
7.2.4. Synthetic Grafts
7.3. Devices
7.3.1. Interbody Fusion
7.3.1.1. Alif
7.3.1.2. Plif
7.3.1.3. Tlif
7.3.1.4. Xlif
7.3.2. Pedicle Screw Systems
7.3.3. Spinal Plates
7.3.4. Vertebral Compression Fracture
8. Spinal Devices & Biologics Market, by Technology
8.1. Introduction
8.2. Conventional Open
8.3. Minimally Invasive
8.4. Navigation Systems
8.5. Robotics
9. Spinal Devices & Biologics Market, by Application
9.1. Introduction
9.2. Deformity
9.3. Degenerative
9.4. Oncology
9.5. Trauma
10. Spinal Devices & Biologics Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Distributors
10.4. Ecommerce
11. Spinal Devices & Biologics Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Clinics
11.4. Hospitals
12. Spinal Devices & Biologics Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Spinal Devices & Biologics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Spinal Devices & Biologics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alphatec Holdings, Inc.
16.2. Amedica Corporation
16.3. Arthrex, Inc.
16.4. B. Braun SE
16.5. Baxter International Inc.
16.6. Bioventus Inc.
16.7. Camber Spine Technologies, LLC
16.8. Companion Spine LLC
16.9. Cook Medical LLC
16.10. CTL Medical Corporation
16.11. Exactech, Inc.
16.12. Globus Medical, Inc.
16.13. Integra LifeSciences Holdings Corporation
16.14. Johnson & Johnson
16.15. Kuros Biosciences A.G.
16.16. Medtronic plc
16.17. Orthofix Medical Inc.
16.18. Spineart SA
16.19. Spineology, Inc.
16.20. Stryker Corporation
16.21. W. Ulrich GmbH
16.22. Xtant Medical Holdings, Inc.
16.23. Zimmer Biomet Holdings, Inc.
List of Figures
FIGURE 1. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ALLOGRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ALLOGRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL AUTOGRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL AUTOGRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL AUTOGRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL RECOMBINANT GROWTH FACTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL RECOMBINANT GROWTH FACTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL RECOMBINANT GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SYNTHETIC GRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SYNTHETIC GRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SYNTHETIC GRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL INTERBODY FUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL INTERBODY FUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL INTERBODY FUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ALIF MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ALIF MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ALIF MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL PLIF MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL PLIF MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PLIF MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL TLIF MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL TLIF MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL TLIF MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL XLIF MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL XLIF MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL XLIF MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PEDICLE SCREW SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PEDICLE SCREW SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PEDICLE SCREW SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SPINAL PLATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SPINAL PLATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SPINAL PLATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CONVENTIONAL OPEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CONVENTIONAL OPEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CONVENTIONAL OPEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL NAVIGATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL NAVIGATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL NAVIGATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ROBOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ROBOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ROBOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DEFORMITY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL DEFORMITY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL DEFORMITY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL DEGENERATIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL DEGENERATIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL DEGENERATIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL TRAUMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL TRAUMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL TRAUMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ECOMMERCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ECOMMERCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ECOMMERCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 120. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 122. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 123. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 124. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 125. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 126. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 127. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 128. EUROPE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 137. MIDDLE EAST SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 138. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 140. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 141. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 142. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 143. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 144. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 145. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 146. AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 149. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 150. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 151. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 152. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 153. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 154. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 155. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 156. ASEAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 159. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 160. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 161. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 162. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 163. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 165. GCC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 176. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 177. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 178. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 179. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 180. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 181. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 182. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 183. BRICS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 185. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 186. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 187. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 188. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 189. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 190. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 191. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 192. G7 SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 193. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 195. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 196. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 197. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 198. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 199. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 200. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 201. NATO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 202. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 203. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 204. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 205. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 206. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 207. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 208. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 209. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 210. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 211. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 212. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 213. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 214. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 215. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 216. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 217. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 218. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 219. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 220. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 221. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 222. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 223. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 224. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 225. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 226. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 227. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 228. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 229. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 231. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 232. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 233. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 234. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 235. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 236. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 238. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 239. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 240. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 241. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 242. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 243. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 244. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 245. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 246. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 247. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 249. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 250. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 251. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 252. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 253. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 254. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 255. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 256. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 257. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 258. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 259. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 260. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 261. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 262. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 263. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 264. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 265. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 268. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 269. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 270. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 271. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 272. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 273. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 274. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 276. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 277. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 278. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 279. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 280. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 281. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 282. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 283. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 286. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 287. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 288. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 289. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 290. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 291. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 292. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 293. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 294. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 295. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 296. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 297. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 298. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 299. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 300. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 301. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 302. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 304. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 305. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 306. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 307. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 308. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 310. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 312. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 313. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 314. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 315. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 316. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 317. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 318. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 319. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 320. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 321. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 322. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 323. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 324. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 325. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 326. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 327. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 328. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 329. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 330. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY PRODUCT CATEGORY, 2017-2032 (USD MILLION)
TABLE 331. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY BIOLOGICS, 2017-2032 (USD MILLION)
TABLE 332. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DEVICES, 2017-2032 (USD MILLION)
TABLE 333. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY INTERBODY FUSION, 2017-2032 (USD MILLION)
TABLE 334. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 335. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 336. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 337. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 338. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 339. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Alphatec Holdings, Inc.
  • Amedica Corporation
  • Arthrex, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Bioventus Inc.
  • Camber Spine Technologies, LLC
  • Companion Spine LLC
  • Cook Medical LLC
  • CTL Medical Corporation
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Kuros Biosciences A.G.
  • Medtronic plc
  • Orthofix Medical Inc.
  • Spineart SA
  • Spineology, Inc.
  • Stryker Corporation
  • W. Ulrich GmbH
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 15.55 Billion
Forecasted Market Value ( USD ) by 2032 $ 40.45 Billion
Compound Annual Growth Rate17.2%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Spine Biologics Market - Global Forecast 2026-2032 - Product Image

Spine Biologics Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Spine Biologics - Global Strategic Business Report - Product Image

Spine Biologics - Global Strategic Business Report

  • Report
  • 382 Pages
  • Global
From
Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2026-2034 - Product Image

Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2026-2034

  • Report
  • 136 Pages
  • Global
From
Spine Biologic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Spine Biologic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Spine Biologics Market Report 2026 - Product Image

Spine Biologics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.